• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000696 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2021-01-05 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2021-03-17 view
JXSL1300034 帕妥珠单抗注射液 pertuzumab Injection Biological Products Import Drug Application 2013-05-23 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2015-08-10 view
JYSB2300063 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2023-04-11 view
JXSL1800044 帕妥珠单抗注射液 pertuzumab Injection Biological Products Import Drug Application 2018-10-29 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2018-10-26 view
JYSB2000386 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2020-08-21 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Filed 2020-09-02 view
JYSB2200111 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2022-06-30 view
JXSS1700018 帕妥珠单抗注射液 pertuzumab Injection Biological Products Import Drug Application 2018-01-02 上海罗氏制药有限公司 Shanghai Roche Pharmaceutical Co Ltd Certificate Issued 2018-12-19 view
CXSS2400116 帕妥珠单抗注射液 pertuzumab Injection Biological Products(3.3) New Drug Application 2024-10-28 Hisun Biopharmaceutical Co Ltd view
JYSB1900363 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2020-01-19 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-03-24 view
JYSB2300016 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2023-02-07 view
JYSB1800226 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2018-10-26 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2018-12-19 view
JYSB2000140 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2020-05-06 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-01 view
JYSB2101061 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2021-06-25 view
CXSL1700090 帕妥珠单抗注射液 pertuzumab Injection Biological Products(2) New Drug Application 2017-10-18 正大天晴药业集团南京顺欣制药有限公司 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group Certificate Issued 2018-05-08 view
JYSB2300197 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2023-11-14 view
JYSB1900081 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2019-04-11 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2019-12-13 view
JYSB2000662 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2020-12-28 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-12-24 view
JXSL1200073 帕妥珠单抗注射液 pertuzumab Injection Biological Products Import Drug Application 2012-12-07 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2014-02-07 view
JYSB2000079 帕妥珠单抗注射液 pertuzumab Injection Biological Products Supplementary Application 2020-03-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd Certificate Issued 2020-07-16 view
CXSL2101162 帕妥珠单抗注射液 pertuzumab Injection Biological Products(3.3) New Drug Application 2021-06-29 CSPC Megalith Biopharmaceutical Co Ltd view